# Cephalgo **Source:** https://www.startuphub.ai/organizations/cephalgo **Profile type:** Startup > Speech biomarker company in Strasbourg, France, for CNS clinical trials ## About Cephalgo is a speech biomarker company in Strasbourg, France. It measures real disease progression in CNS clinical trials (Alzheimer's, Parkinson's, Huntington's, ALS, DM1 and other neuromuscular diseases, and psychiatry) from speech recordings sponsors already hold, from site visits and from home sessions, with readings that stay stable across phone and software changes. Cephalgo also checks recorded rating interviews (Trial QC) so rater effects do not read as participant change. It works with pharmaceutical and biotech sponsors and CROs. ## Key facts - **Slug:** cephalgo - **Website:** https://www.cephalgo.com - **Location:** Strasbourg, France - **Employees:** 6 - **Operating status:** Active - **Sectors / tags:** Clinical Trials, Speech Biomarker, Digital Biomarker, Voice Biomarker, CNS Clinical Trials - **Social:** - LinkedIn: https://www.linkedin.com/company/cephalgo ## StartupHub.ai scores - **Ahrefs DR:** 3/100 - **Agent Readiness:** C (64/100) - **Site Speed:** 89/100 ## Tech stack Detected on cephalgo.com, last scanned 2026-11-17. - **Compliance:** GDPR - **CMS / Builders:** Webflow - **CDN:** Cloudflare - **Email provider:** Google Workspace ## JSON-LD Structured data aligned with this page's `